Price Alert

Basel Medical Group Ltd O... (BMGL)

NASDAQ: BMGL · Real-Time Price · USD

1.97

-0.03 (-1.50%)

At close: Sep 12, 2025, 2:56 PM

Basel Medical Ltd Ordinary Shares Statistics

Share Statistics

Basel Medical Ltd Ordinary Shares has 18.79M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	18.79M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	2,469
FTD / Avg. Volume	0.1%

Short Selling Information

The latest short interest is 487.41K, so 2.59% of the outstanding shares have been sold short.

Short Interest	487.41K
Short % of Shares Out	2.59%
Short % of Float	5.68%
Short Ratio (days to cover)	3.54

Valuation Ratios

The PE ratio is 54.43 and the forward PE ratio is null. Basel Medical Ltd Ordinary Shares's PEG ratio is 3.47.

PE Ratio	54.43
Forward PE	n/a
PS Ratio	11.23
Forward PS	n/a
PB Ratio	14.92
P/FCF Ratio	45.11
PEG Ratio	3.47

Financial Ratio History

Enterprise Valuation

Basel Medical Ltd Ordinary Shares has an Enterprise Value (EV) of 115.17M.

EV / Sales	11.46
EV / EBITDA	37.04
EV / EBIT	45.9
EV / FCF	46.04

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.57.

Current Ratio	2.26
Quick Ratio	2.25
Debt / Equity	0.57
Debt / EBITDA	1.38
Debt / FCF	1.71
Interest Coverage	12.46

Financial Efficiency

Return on Equity is 27.41% and Return on Invested Capital is 15.97%.

Return on Equity	27.41%
Return on Assets	12.71%
Return on Invested Capital	15.97%
Revenue Per Employee	$314.09K
Profits Per Employee	$64.78K
Employee Count	32
Asset Turnover	0.62
Inventory Turnover	31.21

Taxes

Income Tax	331.76K
Effective Tax Rate	13.8%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0, so Basel Medical Ltd Ordinary Shares's price volatility has been lower than the market average.

Beta	0
52-Week Price Change	n/a
50-Day Moving Average	2.16
200-Day Moving Average	n/a
Relative Strength Index (RSI)	47.6
Average Volume (20 Days)	2,414,837

Income Statement

In the last 12 months, Basel Medical Ltd Ordinary Shares had revenue of 10.05M and earned 2.07M in profits. Earnings per share was 0.11.

Revenue	10.05M
Gross Profit	7.8M
Operating Income	2.2M
Net Income	2.07M
EBITDA	3.11M
EBIT	2.58M
Earnings Per Share (EPS)	0.11

Full Income Statement

Balance Sheet

The company has 1.95M in cash and 4.29M in debt, giving a net cash position of -2.34M.

Cash & Cash Equivalents	1.95M
Total Debt	4.29M
Net Cash	-2.34M
Retained Earnings	7.56M
Total Assets	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.51M and capital expenditures -7.92K, giving a free cash flow of 2.5M.

Operating Cash Flow	2.51M
Capital Expenditures	-7.92K
Free Cash Flow	2.5M
FCF Per Share	0.13

Full Cash Flow Statement

Margins

Gross margin is 77.63%, with operating and profit margins of 21.84% and 20.62%.

Gross Margin	77.63%
Operating Margin	21.84%
Pretax Margin	23.92%
Profit Margin	20.62%
EBITDA Margin	30.94%
EBIT Margin	21.84%
FCF Margin	24.89%

Dividends & Yields

BMGL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	1.84%
FCF Yield	2.22%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for BMGL.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	1
Graham Upside	-50%

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a